免疫功能低下患者与免疫能力较强患者差异化甲状腺癌的可比结果
Amit Ritter1, Alana Eagan1, Helena Levyn1
1Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
The Journal of clinical endocrinology and metabolism
|October 7, 2025
概括
差异化甲状腺癌 (DTC) 的预后对于免疫功能低下和免疫能力强的患者来说是相似的. 免疫缺陷在DTC中没有显著影响无复发或特定疾病的生存率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 差异化甲状腺癌 (DTC) 通常具有有利的预后.
- 免疫缺陷对DTC结果的影响尚未得到充分证实,特别是在器官移植接受者之外.
研究的目的:
- 为了比较DTC的临床特征和结果,免疫功能低下与免疫能力较强的个体.
- 调查免疫缺陷对DTC预后的影响.
主要方法:
- 在1987年至2020年期间接受治疗的成人DTC患者的回顾性分析.
- 倾向性得分匹配 (5:1比) 用于比较130名免疫功能低下患者和650名免疫能力较强的对照人群.
主要成果:
- 免疫功能低下和免疫能力较强的DTC患者之间的无复发生存没有显著差异 (p=0.94).
- 在180个月的时间里,复发率在两组中都保持在10%以下.
- 类似的10年疾病特异性存活率:免疫功能低下患者的100%vs免疫能力强患者的98% (p=0.34).
结论:
- 不同化的甲状腺癌显示出与免疫状况无关的可比预后.
- 免疫缺陷似乎不会对DTC结果产生负面影响.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Immunodeficiency Diseases
2.0K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.0K
Cell-mediated Immune Responses
83.5K
Overview
83.5K
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K


